Phase I/II trial of encorafenib, cetuximab, and nivolumab in microsatellite stable, BRAFV600E metastatic colorectal cancer
RNA-seq (gene expression) · human · 62 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Colorectal cancerThis series is part of our curated briefing on it.
- Samples
- 62 samples: 51 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE302923_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1292822 and SRA study SRP601591. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 62 sample titles: 51 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9113690 VM1.1_S12
- GSM9113691 VM1.2_S8
- GSM9113692 VM2.1_S4
- GSM9113693 VM2.2_S23
- GSM9113694 VM3.1_S3
- GSM9113695 VM3.2_S61
- GSM9113696 VM4.1_S2
- GSM9113697 VM4.2_S57
- GSM9113698 VM5.1_S53
- GSM9113699 VM5.2_S5
- GSM9113700 VM6.1_S58
- GSM9113701 VM6.2_S7
- GSM9113702 VM7.1_S20
- GSM9113703 VM7.2_S13
- GSM9113704 VM8.1_S14
- GSM9113705 VM8.2_S63
- GSM9113706 VM9.1_S9
- GSM9113707 VM9.2_S65
- GSM9113708 VM10.1_S22
- GSM9113709 VM10.2_S64
- GSM9113710 VM11.1_S60
- GSM9113711 VM11.2_S66
- GSM9113712 VM12.1_S59
- GSM9113713 VM12.2_S15
- GSM9113714 VM13.1_S21
- GSM9113715 VM13.2_S10
- GSM9113716 VM14.1_S19
- GSM9113717 VM14.2_S11
- GSM9113718 VM15.1_S17
- GSM9113719 VM15.2_S1
- GSM9113720 VM16.1_S62
- GSM9113721 VM16.2_S44
- GSM9113722 VM17.1_S55
- GSM9113723 VM17.2_S48
- GSM9113724 VM18.1_S56
- GSM9113725 VM18.2_S49
- GSM9113726 VM19.1_S54
- GSM9113727 VM19.2_S42
- GSM9113728 VM20.1_S50
- GSM9113729 VM20.2_S51
+ 22 more — browse all 62 samples with per-sample file links →
- GSE250000 Bulk RNA-sequencing of transduced colorectal cancer cell line HCT-116 and breast cancer cell line MCF-7 overexpressing full-lenght p53β or p53β-stop-lost. 4 samples same disease briefing · shares colorectal
- GSE12032 Inherent gene signature of stage II and III colorectal cancer leads in individual recurrence 198 samples same disease briefing · shares colorectal
- GSE110009 Single cell transcriptome landscape of primary and metastatic tumor in colon cancer 76 samples same disease briefing · shares metastatic
- GSE109308 Single-cell transcriptomic survey of adenomatous polyposis patients with germline APC mutations 97 samples same disease briefing
- GSE302921 Phase I/II trial of encorafenib, cetuximab, and nivolumab in microsatellite stable, BRAFV600E metastatic colorectal cancer [dataset 1] 50 samples shares brafv600e, microsatellite, encorafenib, metastatic, colorectal, cetuximab, nivolumab, stable
- GSE302922 Phase I/II trial of encorafenib, cetuximab, and nivolumab in microsatellite stable, BRAFV600E metastatic colorectal cancer [dataset 2] 12 samples shares brafv600e, microsatellite, encorafenib, metastatic, colorectal, cetuximab, nivolumab, stable
- GSE307398 Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer 12 samples shares microsatellite, metastatic, colorectal, stable
- GSE319722 Spatial dynamics links PD-L1 and Tumor-Associated Macrophage–Enriched Niches to Immune and Mesenchymal States in microsatellite stable colorectal cancer 117 samples shares microsatellite, colorectal, stable
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.